Glen Giese

Title: Glen Giese: Innovator in Bispecific Antibody Production

Introduction

Glen Giese is a notable inventor based in Belmont, CA, who has made significant contributions to the field of biotechnology. He holds a total of 3 patents that focus on the efficient production of bispecific antibodies. His work is pivotal in advancing therapeutic options for various medical conditions.

Latest Patents

Glen Giese's latest patents include innovative methods for the assembly of bispecific antibodies. These methods describe the efficient production of heteromultimeric proteins, which are capable of binding to multiple target molecules or different epitopes on a single target molecule. The techniques outlined in his patents modulate various parameters to enhance the assembly of these proteins, achieving higher yields and efficiencies than previously possible. Additionally, the patents detail compositions that include hinge-containing polypeptides, such as half-antibodies.

Career Highlights

Glen Giese is currently employed at Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. His work at Genentech has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to biotechnology.

Collaborations

Glen has worked alongside notable colleagues such as Amy Lim and Josefine Persson. Their collaborative efforts have contributed to the advancement of research and development in bispecific antibody production.

Conclusion

Glen Giese's innovative work in the field of bispecific antibodies exemplifies the importance of research and development in biotechnology. His patents not only enhance the efficiency of protein assembly but also pave the way for new therapeutic possibilities.